Skip to main
AMN

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 57%
Hold 14%
Sell 14%
Strong Sell 0%

Bulls say

AMN Healthcare Services Inc reported a revenue of $658.2 million for the second quarter of 2025, which, despite being down 11% year-over-year, surpassed the estimates of both the analyst and consensus. The company's gross margin increased to 29.8%, exceeding the high-end of its guidance by 120 basis points, while the gross margin for the nurse and allied solutions segment rose to 28.2%. Moreover, AMN has consistently demonstrated strong performance with an average revenue surprise of +3% and an EBITDA surprise of +12% over the past four quarters, highlighting its ability to outperform expectations.

Bears say

AMN Healthcare Services Inc reported a decrease in segment revenue for its nurse and allied solutions segment, falling 9% year-over-year to $101.8 million, despite exceeding estimates. The company's physician and leadership solutions segment also faced challenges, with revenues declining 14% year-over-year to $381.9 million, although it slightly surpassed expectations. Additionally, the overall operating margin fell by 30 basis points quarter-over-quarter to 7.5%, indicating tightening profit margins amid a challenging revenue environment, particularly with a significant 31% year-over-year drop in vendor management system revenue.

AMN has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 7 analysts, AMN has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.